NOVEL XANTHINES HAVING ADENOSINE A1-RECEPTOR ANTAGONIST PROPERTIES

Details for Australian Patent Application No. 2003261206 (hide)

Owner ARYX THERAPEUTICS

Inventors DRUZGALA, Pascal

Pub. Number AU-A-2003261206

PCT Number PCT/US03/22785

PCT Pub. Number WO2004/009594

Priority 60/397,099 19.07.02 US

Filing date 21 July 2003

Wipo publication date 9 February 2004

International Classifications

C07D 473/06 Heterocyclic compounds containing purine ring systems

A61K 031/52

Event Publications

20 November 2003 Complete Application Filed

  Priority application(s): 60/397,099 19.07.02 US

18 March 2004 Application Open to Public Inspection

  Published as AU-A-2003261206

26 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003261207-APPARATUS AND METHOD FOR NON-DESTRUCTIVE INSPECTION ON A PATTERNED SURFACE

2003261205-NANOSCALE COHERENT OPTICAL COMPONENTS